Bayesian statistics have been used in regulatory submissions to the Food and Drug Administration (FDA) for over 15 years in confirmatory clinical trials of medical devices. In this webinar, Dr. Gregory Campbell, former Director of Biostatistics, U.S. Food and Drug Administration, reviews the history and accomplishments of Bayesian methods in study of medical devices. He further discusses opportunities, challenges, and status of Bayesian statistics for pharmaceutical drugs and biologicals as well as in the overall regulatory environment. Register here.
You are here: / / [Webinar] Bayesian Statistics and FDA Regulatory Acceptability